While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone mineral density, a ...

Obesity in an ageing population 'is biggest issue for the ... a new class of drug which mimics the action of GLP-1 - a naturally occurring gut hormone which is released after eating. Their effect is ...

Metabolic diseases, such as cardiovascular diseases and type 2 diabetes, have become one of the world’s largest public health ...

As the battle against obesity and diabetes heats up, two new superstars are entering the ring in Spain - Mounjaro (also known ...

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced participation in the following investor conferenc ...

According to Dr Rakesh Kumar Prasad, Consultant in Diabetology and Endocrinology at Fortis Hospital, Noida, while not ...

The United Kingdom will study whether the use of weight loss drugs could get people back to work. UK Health Minister Wes ...

Researchers at the University of Copenhagen have identified a promising new drug target for weight loss which could revolutionise treatment for millions of people with obesity and type 2 diabetes. The ...

thyroid hormone receptor-beta (THR-β) agonist In June, Terns presented new preclinical data at the American Diabetes ...